S. Slater

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Richard Fox, Daniel H. Palmer, Hassan Malik et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +9

Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report

Alicia Okines, Ruth E. Langley, Lindsay C Thompson et al. · Annals of Oncology · 2012 · 67 citations · Full text

Medicine, Oncology, Surgery +16

Lithium and clozapine-induced neutropenia/agranulocytosis

R Blier, S. Slater, T. Measham et al. · International Clinical Psychopharmacology · 1998 · 62 citations

Medicine, Pharmacology, Pharmacotherapy +15

A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors

Bojana Milojkovic Kerklaan, S. Slater, Michael Flynn et al. · Investigational New Drugs · 2016 · 32 citations

Medicine, Oncology, Pharmacology +16

Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers – a new active regimen

S. Slater, Jonathan Shamash, Peter Wilson et al. · British Journal of Cancer · 2002 · 16 citations · Full text

Medicine, Oncology, Pharmacotherapy +13